We have had data....that is why they were especially selected for the international Phase 3 GBM trial.
How much data do you want ? - if indeed data drives price ....why are we at this cap ?
So indeed as you say, data will move the SP......what if the forthcoming data readouts are poor. We go lower if your thoughts are correct....much lower if all 3 readouts are poor.
So taking what you say about data moving the SP - poor future results and maybe a SP of 85cents - M/C of US$70 in that very high profile GBM trial. Does not make sense - but hey, as you say data moves the SP.
The issue here was those horrible capital raising and the way they promote - but more importantly looking to the future and the very real possibility of more poor decision making by management.
- Forums
- ASX - By Stock
- KZA
- Kazia Share Price
Kazia Share Price, page-389
-
- There are more pages in this discussion • 403 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online